General Information of Drug-Metabolizing Enzyme (DME ID: DME0566)
DME Name Prostaglandin dehydrogenase 1 (HPGD), Homo sapiens DME Info
UniProt ID
PGDH_HUMAN
EC Number    EC: 1.1.1.141     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
CH-OH donor oxidoreductase
NAD/NADP oxidoreductase
EC: 1.1.1.141
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2A00 Brain cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Melanocytoma Moderate hypomethylation
Interaction Name DNMT-HPGD interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 4.87E-03; delta-beta: -2.82E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HPGD gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between DNMT and HPGD can moderatly affect the drug-metabolizing process of Prostaglandin dehydrogenase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B62 Tongue squamous cell carcinoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-21-3p Tongue squamous cell carcinoma Suppression
miRBase ID
MIMAT0004494
Interaction Name hsa-miR-21-3p--HPGD regulation [1]
Studied Cell Lines UM1, UM2, SCC9 and Tca8113 cell lines
Description hsa-miR-21-3p is reported to suppress HPGD mRNA translation by binding to the 3' untranslated region (3'UTR) of HPGD mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1.
               ICD-11: 2C12 Liver cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-21-5p Liver cancer Suppression
miRBase ID
MIMAT0000076
Interaction Name hsa-miR-21-5p--HPGD regulation [2]
Studied Cell Lines CCLP1, SG231, HuCCT1 and TFK1 cell lines
Description hsa-miR-21-5p is reported to suppress HPGD mRNA translation by binding to the 3' untranslated region (3'UTR) of HPGD mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1.
               ICD-11: 2C25 Lung cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Transcription-factor regulation
                            Zinc finger SNAI2 (SNAI2) Lung cancer Repression
Uniprot ID
SNAI2_HUMAN
Interaction Name SNAI2-HPGD interaction [3]
Studied Cell Lines NSCLC cell line
Ensembl ID
ENSG00000019549
Description Zinc finger SNAI2 (SNAI2) is reported to repress the transcription of HPGD gene, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between SNAI2 and HPGD can repress the drug-metabolizing process of Prostaglandin dehydrogenase 1.
               ICD-11: 2E06 Prostate cancer metastasis Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Prostate cancer metastasis Significant hypomethylation
Interaction Name DNMT-HPGD interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 9.20E-07; delta-beta: -4.15E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HPGD gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between DNMT and HPGD can significantly affect the drug-metabolizing process of Prostaglandin dehydrogenase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma. BMC Cancer. 2016 Aug 25;16(1):685.
2 miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth. Mol Cancer Ther. 2014 Jun;12(6):890-900.
3 Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Cancer Res. 2007 Jun 15;67(12):5587-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.